Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis.

The nAb titre in male MS patients was relatively high ( Figure 1G ), similar to some previous reports on response to COVID-19 status, [ 14 ] but this did not reach statistical significance.

also in 111,027 other papers